{"id":"tp-54209","type":"article-newspaper","title":"Ocugen Agrees to Sell OCU400 Rights in Australia, New Zealand and the ASEAN Region","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/54209","datePublished":"2026-11-11T16:20:23.000Z","dateModified":"2026-11-11T16:20:23.000Z","language":"en","abstract":"The agreement would give Australian biopharma Celairis Therapeutics exclusive commercialization rights to the gene therapy candidate in those areas.","section":"Business","references":[]}